Literature DB >> 1775419

Dapsone in Henoch-Schönlein purpura--worth a trial.

B I Hoffbrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1775419      PMCID： PMC2399133          DOI： 10.1136/pgmj.67.793.961

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  17 in total

1.  Treatment of dermatitis herpetiformis with diamino-diphenyl-sulphone (D.D.S.).

Authors:  E E KRUIZINGA; H HAMMINGA
Journal:  Dermatologica       Date:  1953

Review 2.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates--in comparison with that of colchicine and various scavengers.

Authors:  Y Niwa; T Sakane; Y Miyachi
Journal:  Biochem Pharmacol       Date:  1984-08-01       Impact factor: 5.858

4.  Reduction of neutrophil-mediated injury to pulmonary endothelial cells by dapsone.

Authors:  W J Martin; D L Kachel
Journal:  Am Rev Respir Dis       Date:  1985-04

Review 5.  Is Henoch-Schönlein purpura the systemic form of IgA nephropathy?

Authors:  F B Waldo
Journal:  Am J Kidney Dis       Date:  1988-11       Impact factor: 8.860

6.  Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.

Authors:  R Melsom; M Harboe; B Myrvang; T Godal; A Belehu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

7.  Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.

Authors:  J S Fortson; J J Zone; M E Hammond; G C Groggel
Journal:  J Am Acad Dermatol       Date:  1986-11       Impact factor: 11.527

8.  [Value of dapsone in the treatment of digestive manifestations of rheumatoid purpura in adults].

Authors:  P Chamouard; R Baumann; G Thomas; J P Weill
Journal:  Ann Med Interne (Paris)       Date:  1987

Review 9.  Immune-complex vasculitis: role of complement and IgG-Fc receptor functions.

Authors:  J D Smiley; S E Moore
Journal:  Am J Med Sci       Date:  1989-10       Impact factor: 2.378

10.  Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases.

Authors:  M F Fredenberg; F D Malkinson
Journal:  J Am Acad Dermatol       Date:  1987-04       Impact factor: 11.527
View more
  3 in total

Review 1.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

2.  Dapsone in Henoch-Schönlein purpura.

Authors:  P S Sarma
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

3.  Treatment of refractory IgA vasculitis with dapsone: a systematic review.

Authors:  Keum Hwa Lee; Sung Hwi Hong; Jinhae Jun; Youngheun Jo; Woogyeong Jo; Dayeon Choi; Jeongho Joo; Guhyun Jung; Sunghee Ahn; Andreas Kronbichler; Michael Eisenhut; Jae Il Shin
Journal:  Clin Exp Pediatr       Date:  2019-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.